Pluristem's deal with Chinese investor terminated

On June 20, Pluristem Therapeutics Inc. (NASDAQ:PSTI; Tel Aviv:PSTI) disclosed that plans had been terminated for the company to receive a $30 million investment from China's Innovative Medical Management Co. Ltd. (SZSE:002173) (see BioCentury, Oct. 31, 2016).

Pluristem said the deal fell through "due to a recently adopted Chinese policy relating to outbound investments by Chinese companies."...